Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Roblox
RBLX
|
+$557M |
| 2 |
JPMorgan Chase
JPM
|
+$497M |
| 3 |
Amazon
AMZN
|
+$492M |
| 4 |
AT&T
T
|
+$448M |
| 5 |
Coinbase
COIN
|
+$338M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Advanced Micro Devices
AMD
|
+$706M |
| 3 |
Qualcomm
QCOM
|
+$580M |
| 4 |
Adobe
ADBE
|
+$542M |
| 5 |
Johnson & Johnson
JNJ
|
+$455M |
Sector Composition
| 1 | Healthcare | 19.45% |
| 2 | Technology | 17.76% |
| 3 | Consumer Staples | 10.28% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Financials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3101
NetEase
NTES
$96.8B
| $478K | ﹤0.01% |
4,700
-686,516
| -99% | -$69.8M |
|
3102
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.15B
| $475K | ﹤0.01% |
+6,800
| New | +$475K |
|
3103
Birks Group
BGI
$16.4M
| $474K | ﹤0.01% |
97,806
+14,010
| +17% | +$67.9K |
|
3104
REV Group
REVG
$3.02B
| $474K | ﹤0.01% |
33,500
-65,500
| -66% | -$927K |
|
|
STAB
3105
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $474K | ﹤0.01% |
206,035
+91,837
| +80% | +$211K |
|
3106
Minerva Neurosciences
NERV
$15.2M
| $473K | ﹤0.01% |
73,888
-20,377
| -22% | -$130K |
|
|
EAR
3107
DELISTED
Eargo, Inc. Common Stock
EAR
| $471K | ﹤0.01% |
+4,620
| New | +$471K |
|
3108
iShares US Consumer Discretionary ETF
IYC
$1.75B
| $470K | ﹤0.01% |
5,600
-300
| -5% | -$25.2K |
|
|
MOR
3109
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $469K | ﹤0.01% |
49,800
-1,820
| -4% | -$17.1K |
|
3110
Alerus Financial
ALRS
$577M
| $468K | ﹤0.01% |
+16,000
| New | +$468K |
|
3111
VanEck Agribusiness ETF
MOO
$627M
| $468K | ﹤0.01% |
4,900
+2,400
| +96% | +$229K |
|
3112
Biglari Holdings Class B
BH
$943M
| $467K | ﹤0.01% |
3,276
-688
| -17% | -$98.1K |
|
3113
Flora Growth
FLGC
$14M
| $467K | ﹤0.01% |
+336
| New | +$467K |
|
3114
Armata Pharmaceuticals
ARMP
$107M
| $465K | ﹤0.01% |
84,796
-21,296
| -20% | -$117K |
|
3115
iShares International Select Dividend ETF
IDV
$5.88B
| $461K | ﹤0.01% |
14,800
-37,100
| -71% | -$1.16M |
|
3116
iShares US Medical Devices ETF
IHI
$4.27B
| $461K | ﹤0.01% |
7,000
-2,700
| -28% | -$178K |
|
3117
First Western Financial
MYFW
$228M
| $461K | ﹤0.01% |
+15,200
| New | +$461K |
|
3118
SkyWater Technology
SKYT
$509M
| $461K | ﹤0.01% |
+28,401
| New | +$461K |
|
3119
Erie Indemnity
ERIE
$17.7B
| $457K | ﹤0.01% |
+2,371
| New | +$457K |
|
3120
Dogness International Corp
DOGZ
$186M
| $455K | ﹤0.01% |
2,707
+1,892
| +232% | +$318K |
|
3121
Mirum Pharmaceuticals
MIRM
$3.73B
| $453K | ﹤0.01% |
28,400
-6,900
| -20% | -$110K |
|
3122
Fluence Energy
FLNC
$917M
| $452K | ﹤0.01% |
+12,700
| New | +$452K |
|
|
MYND
3123
Mynd.ai
MYND
$34.2M
| $451K | ﹤0.01% |
22,761
-990
| -4% | -$19.6K |
|
|
OYST
3124
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $451K | ﹤0.01% |
24,700
-87,600
| -78% | -$1.6M |
|
3125
Aethlon Medical
AEMD
$2.01M
| $450K | ﹤0.01% |
3,028
+2,393
| +377% | +$356K |
|